Wave Life Sciences announced that CEO Paul Bolno will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on November 18, 2026. The event will be webcast live and later available for replay on the company's investor website. Wave Life Sciences focuses on RNA medicines with key programs targeting obesity, alpha-1 antitrypsin deficiency, and liver disease. This presentation offers investors insight into the company's progress and future plans in RNA-based therapies.
Wave Life Sciences is presenting at the Jefferies Global Healthcare Conference in London. For readers following the health sector, here is Pluang's market snapshot as of Nov 11, 2026 20:11 WIB: Among 150 priced US health stocks, 69 rose and 74 fell today. Notable movers include Alcon AG (ALC) at USD 71.61 with 0% sell and 100% buy order activity, Butterfly Network Inc. (BFLY) up 2.92% to USD 6.70, and MiniMed Group Inc. (MMED) up 2.59% to USD 17.81. Typical hold times range from 15 to 72 days on Pluang.
The global telehealth market, valued at $77.4 billion in 2025, is projected to expand to $187.5 billion by 2033, driven by increasing patient demand for virtual care and advances in AI, remote monitoring, and wearable health devices. Companies like R...
The Portnoy Law Firm is investigating Arbor Realty Trust, Inc. for possible securities fraud following the company's October 30, 2026 announcement to suspend its quarterly cash dividend due to financial challenges. This announcement caused Arbor's st...
RUM Group Inc. reported a record quarterly revenue of $96.6 million for Q3 2026, a 290% increase year-over-year, surpassing expectations. Despite this, earnings per share were -$0.19, missing the estimate of -$0.11. The company achieved its first pro...
Richtech Robotics announced its Intelligent Cleaning System at ISSA Show North America 2026, which integrates autonomous cleaning robots with CCTV cameras to enable proactive, targeted cleaning. This system uses real-time data to optimize cleaning ta...
The 2026 Vertex CompOps™ Index reveals that just 16% of enterprises regularly discuss indirect tax at the board level, while 43% only address it when issues arise. Companies with board-level focus on indirect tax are four times less likely to have er...
